Osmosis Pür Medical Skincare Catalyst Serums Receive Patent Approval

Osmosis Pür Medical Skincare has been awarded patents by the U.S. Patent and Trademark Office for its formulas in three of its Catalyst products—Catalyst, Catalyst Plus, and Catalyst AC-11. The three products combine amino acids and Zinc Finger Technology (ZFT) engineered proteins to repair DNA damage and assist in the production of proteins and antioxidants in the cells. It also helps improve scarring, skin tags, actinic keratosis, capillaries, and other conditions related to DNA damage. Founded by Ben Johnson, M.D., Osmosis Pür Medical Skincare is sold in spas and specialty retailers nationwide and collectively holds more than 15 patent-pending formulas.—Jessica Morrobel

Suggested Articles

Crown is now poised to become a global leader in dermatology health and wellness.

Holly Cutler shares her expert thoughts on what to expect from medical spas in 2020.

Allergan Aesthetics will operate as a new business with its own research and development function under the AbbVie umbrella.